1. Home
  2. IVVD vs TSQ Comparison

IVVD vs TSQ Comparison

Compare IVVD & TSQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IVVD
  • TSQ
  • Stock Information
  • Founded
  • IVVD 2020
  • TSQ 1996
  • Country
  • IVVD United States
  • TSQ United States
  • Employees
  • IVVD N/A
  • TSQ N/A
  • Industry
  • IVVD Biotechnology: Pharmaceutical Preparations
  • TSQ Broadcasting
  • Sector
  • IVVD Health Care
  • TSQ Consumer Discretionary
  • Exchange
  • IVVD Nasdaq
  • TSQ Nasdaq
  • Market Cap
  • IVVD 123.8M
  • TSQ 101.3M
  • IPO Year
  • IVVD 2021
  • TSQ 2000
  • Fundamental
  • Price
  • IVVD $0.59
  • TSQ $7.10
  • Analyst Decision
  • IVVD Strong Buy
  • TSQ Buy
  • Analyst Count
  • IVVD 3
  • TSQ 1
  • Target Price
  • IVVD $7.52
  • TSQ $15.00
  • AVG Volume (30 Days)
  • IVVD 1.9M
  • TSQ 62.4K
  • Earning Date
  • IVVD 05-15-2025
  • TSQ 05-08-2025
  • Dividend Yield
  • IVVD N/A
  • TSQ 11.70%
  • EPS Growth
  • IVVD N/A
  • TSQ N/A
  • EPS
  • IVVD N/A
  • TSQ N/A
  • Revenue
  • IVVD $25,384,000.00
  • TSQ $450,024,000.00
  • Revenue This Year
  • IVVD $606.63
  • TSQ N/A
  • Revenue Next Year
  • IVVD $83.30
  • TSQ $6.71
  • P/E Ratio
  • IVVD N/A
  • TSQ N/A
  • Revenue Growth
  • IVVD N/A
  • TSQ N/A
  • 52 Week Low
  • IVVD $0.36
  • TSQ $6.47
  • 52 Week High
  • IVVD $2.74
  • TSQ $12.74
  • Technical
  • Relative Strength Index (RSI)
  • IVVD 46.76
  • TSQ 50.04
  • Support Level
  • IVVD $0.49
  • TSQ $6.73
  • Resistance Level
  • IVVD $0.80
  • TSQ $7.09
  • Average True Range (ATR)
  • IVVD 0.08
  • TSQ 0.27
  • MACD
  • IVVD 0.01
  • TSQ 0.08
  • Stochastic Oscillator
  • IVVD 32.79
  • TSQ 61.76

About IVVD Invivyd Inc.

Invivyd Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of antibody-based solutions for infectious diseases with pandemic potential. The company is developing antibodies to transcend the limits of naturally occurring immunity and provide superior protection from viral diseases, beginning with COVID-19. The company's product candidates are; ADG20 developed for the treatment and prevention of coronavirus disease, and VYD222, a monoclonal antibody candidate engineered, optimizing for potency and breadth of coverage, as well as providing a higher probability of retaining its utility for a longer duration in an evolving viral landscape.

About TSQ Townsquare Media Inc.

Townsquare Media Inc is a radio, digital media, entertainment, and digital marketing solutions company principally focused on being the premier local advertising and marketing solutions platform in small and mid-sized markets across the United States. It has three segments which are Subscription Digital Marketing Solutions, Digital Advertising, and Broadcast Advertising. It earns the majority of the revenue from the Broadcasting Advertising segment, which includes its local, regional, and national advertising products and solutions delivered via terrestrial radio broadcast. Its portfolio includes local media brands such as WYRK.com, WJON.com, and NJ101.5.com, and premier national music brands such as XXLmag.com, TasteofCountry.com, UltimateClassicRock.com, and Loudwire.com.

Share on Social Networks: